Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas W Geisbert

Showing results (141-150 of 279) with videos related to

Pageof 28
Sort By:
NPJ Vaccines|January 3, 2026
A single-cycle recombinant VSV vaccine displaying the Hendra virus glycoprotein uniformly protects against Hendra and Nipah virus challengeDeclan D Pigeaud, Viktoriya Borisevich, Krystle N Agans, et al.
Cell Host & Microbe|July 23, 2013
Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcomePriya Luthra, Parameshwaran Ramanan, Chad E Mire, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2004
The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate modelKathleen H Rubins, Lisa E Hensley, Peter B Jahrling, et al.
Nature|January 7, 2026
Oral 4'-fluorouridine rescues nonhuman primates from advanced Lassa feverRobert W Cross, Jacquelyn Turcinovic, Abhishek N Prasad, et al.
Lab on a Chip|February 15, 2017
Disposable cartridge platform for rapid detection of viral hemorrhagic fever virusesSteven M Scherr, David S Freedman, Krystle N Agans, et al.
The Journal of Infectious Diseases|November 6, 2019
A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus InfectionChad E Mire, Yee-Peng Chan, Viktoriya Borisevich, et al.
The Journal of Infectious Diseases|December 6, 2007
Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic feverLisa E Hensley, Edward L Stevens, S Betty Yan, et al.
Msphere|June 16, 2016
Isolation and Characterization of a Novel Gammaherpesvirus from a Microbat Cell LineReed S Shabman, Susmita Shrivastava, Tshidi Tsibane, et al.
Vaccine|October 22, 2008
Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg virusesThomas W Geisbert, Kathleen M Daddario-Dicaprio, Joan B Geisbert, et al.
Emerging Infectious Diseases|July 24, 2009
Potential impact of a 2-person security rule on BioSafety Level 4 laboratory workersJames W LeDuc, Kevin Anderson, Marshall E Bloom, et al.
Pageof 28

Showing results (141-150 of 279) with videos related to

Sort By:
Pageof 28
NPJ Vaccines|January 3, 2026
A single-cycle recombinant VSV vaccine displaying the Hendra virus glycoprotein uniformly protects against Hendra and Nipah virus challengeDeclan D Pigeaud, Viktoriya Borisevich, Krystle N Agans, et al.
Cell Host & Microbe|July 23, 2013
Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcomePriya Luthra, Parameshwaran Ramanan, Chad E Mire, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2004
The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate modelKathleen H Rubins, Lisa E Hensley, Peter B Jahrling, et al.
Nature|January 7, 2026
Oral 4'-fluorouridine rescues nonhuman primates from advanced Lassa feverRobert W Cross, Jacquelyn Turcinovic, Abhishek N Prasad, et al.
Lab on a Chip|February 15, 2017
Disposable cartridge platform for rapid detection of viral hemorrhagic fever virusesSteven M Scherr, David S Freedman, Krystle N Agans, et al.
The Journal of Infectious Diseases|November 6, 2019
A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus InfectionChad E Mire, Yee-Peng Chan, Viktoriya Borisevich, et al.
The Journal of Infectious Diseases|December 6, 2007
Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic feverLisa E Hensley, Edward L Stevens, S Betty Yan, et al.
Msphere|June 16, 2016
Isolation and Characterization of a Novel Gammaherpesvirus from a Microbat Cell LineReed S Shabman, Susmita Shrivastava, Tshidi Tsibane, et al.
Vaccine|October 22, 2008
Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg virusesThomas W Geisbert, Kathleen M Daddario-Dicaprio, Joan B Geisbert, et al.
Emerging Infectious Diseases|July 24, 2009
Potential impact of a 2-person security rule on BioSafety Level 4 laboratory workersJames W LeDuc, Kevin Anderson, Marshall E Bloom, et al.
Pageof 28